Novocuff
Mountain View, US · Founded 2022 · Delaware corporation · 11 employees on LinkedIn · 3 known investors
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.
Founders & leadership
DL
Donald LeeExecutive
AD
Amelia DegenkolbExecutive
AD
Amy Degenkolb
Board
LD
Lilly DeSouza BurrBoard director
CL
Curt LaBelleBoard director
RS
SP
Shacey PetrovicBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 1 round · 2024
▶$6.8MraisedJul 2024 · 31 investors · Other Health CareRule 506(b)
▶$6.8MraisedJul 2024 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shacey PetrovicDirector
- Donald LeeExecutive Officer
- Lilly DeSouza BurrDirector
- Curt LaBelleDirector
- Rebecca ShmuklerDirector
- Amelia DegenkolbExecutive Officer, Director
- Offering amount
- $28M
- Amount sold
- $6.8M
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Novocuff do?
- Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.
- Who are Novocuff's investors?
- Novocuff's investors include Foreground Capital, Laerdal Million Lives Fund, Tullis.
- How much funding has Novocuff raised?
- Novocuff has disclosed $6.8M raised across 1 round.
- Where is Novocuff headquartered?
- Novocuff is headquartered in Mountain View, US.